Matinas biopharma appoints hui liu, ph.d., m.b.a. as chief technology officer

– dr. liu brings more than 20 years of expertise in pharmaceutical development, formulation, and cmc, with specific focus on lipid-based delivery of complex molecules – – dr. liu brings more than 20 years of expertise in pharmaceutical development, formulation, and cmc, with specific focus on lipid-based delivery of complex molecules –
MTNB Ratings Summary
MTNB Quant Ranking